Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.56 USD | +2.30% | +0.65% | -15.22% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 66.53M | Sales 2025 * | 80.63M | Capitalization | 173M |
---|---|---|---|---|---|
Net income 2024 * | -43M | Net income 2025 * | -37M | EV / Sales 2024 * | 2.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.15 x |
P/E ratio 2024 * |
-3.81
x | P/E ratio 2025 * |
-4.97
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.82% |
Latest transcript on Biodesix, Inc.
1 day | +2.30% | ||
1 week | +0.65% | ||
Current month | +25.81% | ||
1 month | +24.80% | ||
3 months | -0.64% | ||
6 months | +7.59% | ||
Current year | -15.22% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 11-02-28 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 08-05-31 |
Jack Schuler
BRD | Director/Board Member | 83 | 11-12-31 |
Jon Kayyem
BRD | Director/Board Member | 60 | 21-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 1.56 | +2.30% | 83,629 |
24-05-15 | 1.525 | +2.01% | 76,288 |
24-05-14 | 1.495 | -1.64% | 187,057 |
24-05-13 | 1.52 | -3.80% | 95,821 |
24-05-10 | 1.58 | +1.94% | 100,929 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.22% | 173M | |
-15.71% | 8.57B | |
+65.60% | 4.3B | |
-9.46% | 2.47B | |
-2.16% | 2.46B | |
-44.11% | 2.31B | |
-7.42% | 1.93B | |
-18.68% | 1.53B | |
-41.75% | 1.2B | |
+11.31% | 1.14B |
- Stock Market
- Equities
- BDSX Stock